|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, et al: The 2007 WHO classification of
tumours of the central nervous system. Acta Neuropathol.
114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bondy ML, Scheurer ME, Malmer B,
Barnholtz-Sloan JS, Davis FG, Il’yasova D, et al: Brain tumor
epidemiology: consensus from the Brain Tumor Epidemiology
Consortium. Cancer. 113:1953–1968. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gurney JG and Kadan-Lottick N: Brain and
other central nervous system tumors: rates, trends, and
epidemiology. Curr Opin Oncol. 13:160–166. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ornitz DM and Itoh N: Fibroblast growth
factors. Genome Biol. 2:reviews3005.1–reviews3005.12. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Itoh N and Ornitz DM: Evolution of the
Fgf and Fgfr gene families. Trends Genet. 20:563–569.
2004.
|
|
6
|
Miki T, Bottaro DP, Fleming TP, Smith CL,
Burgess WH, Chan AM and Aaronson SA: Determination of
ligand-binding specificity by alternative splicing: two distinct
growth factor receptors encoded by a single gene. Proc Natl Acad
Sci USA. 89:246–250. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hunter DJ, Kraft P, Jacobs KB, Cox DG,
Yeager M, Hankinson SE, et al: A genome-wide association study
identifies alleles in FGFR2 associated with risk of sporadic
postmenopausal breast cancer. Nat Genet. 39:870–874. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Byron SA, Gartside MG, Wellens CL, Mallon
MA, Keenan JB, Powell MA, et al: Inhibition of activated fibroblast
growth factor receptor 2 in endometrial cancer cells induces cell
death despite PTEN abrogation. Cancer Res. 68:6902–6907. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Byron SA and Pollock PM: FGFR2 as a
molecular target in endometrial cancer. Future Oncol. 5:27–32.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Byron SA, Gartside MG, Wellens CL,
Goodfellow PJ, Birrer MJ, Campbell IG and Pollock PM: FGFR2
mutations are rare across histologic subtypes of ovarian cancer.
Gynecol Oncol. 117:125–129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsuda Y, Ishiwata T, Yamahatsu K,
Kawahara K, Hagio M, Peng WX, et al: Overexpressed fibroblast
growth factor receptor 2 in the invasive front of colorectal
cancer: a potential therapeutic target in colorectal cancer. Cancer
Lett. 309:209–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ishiwata T, Matsuda Y, Yamamoto T, Uchida
E, Korc M and Naito Z: Enhanced expression of fibroblast growth
factor receptor 2 IIIc promotes human pancreatic cancer cell
proliferation. Am J Pathol. 180:1928–1941. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamaguchi F, Saya H, Bruner JM and
Morrison RS: Differential expression of two fibroblast growth
factor-receptor genes is associated with malignant progression in
human astrocytomas. Proc Natl Acad Sci USA. 91:484–488. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamada SM, Yamaguchi F, Brown R, Berger MS
and Morrison RS: Suppression of glioblastoma cell growth following
antisense oligonucleotide-mediated inhibition of fibroblast growth
factor receptor expression. Glia. 28:66–76. 1999. View Article : Google Scholar
|
|
15
|
Matsuda Y, Fujii T, Suzuki T, Yamahatsu K,
Kawahara K, Teduka K, et al: Comparison of fixation methods for
preservation of morphology, RNAs, and proteins from
paraffin-embedded human cancer cell-implanted mouse models. J
Histochem Cytochem. 59:68–75. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishiwata T, Naito Z, Lu YP, Kawahara K,
Fujii T, Kawamoto Y, Teduka K and Sugisaki Y: Differential
distribution of fibroblast factor-7 and FGF-10 in
L-arginine-induced pancreatitis. Exp Mod Pathol. 73:181–190. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eswarakumar VP, Lax I and Schlessinger J:
Cellular signaling by fibroblast growth factor receptors. Cytokine
Growth Factor Rev. 16:139–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mattei MG, Moreau A, Gesnel MC, Houssaint
E and Breathnach R: Assignment by in situ hybridization of a
fibroblast growth factor receptor gene to human chromosome band
10q26. Hum Genet. 87:84–86. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rasheed BK, Fuller GN, Friedman AH, Bigner
DD and Bigner SH: Loss of heterozygosity for 10q loci in human
gliomas. Genes Chromosomes Cancer. 5:75–82. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kwabi-Addo B, Ropiquet F, Giri D and
Ittmann M: Alternative splicing of fibroblast growth factor
receptors in human prostate cancer. Prostate. 46:163–172. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valve E, Martikainen P, Seppänen J,
Oksjoki S, Hinkka S, Anttila L, et al: Expression of fibroblast
growth factor (FGF)-8 isoforms and FGF receptors in human ovarian
tumors. Int J Cancer. 88:718–725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Drugan CS, Paterson IC and Prime SS:
Fibroblast growth factor receptor expression reflects cellular
differentiation in human oral squamous carcinoma cell lines.
Carcinogenesis. 19:1153–1156. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cha JY, Lambert QT, Reuther GW and Der CJ:
Involvement of fibroblast growth factor receptor 2 isoform
switching in mammary oncogenesis. Mol Cancer Res. 6:435–445. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chaffer CL, Brennan JP, Slavin JL, Blick
T, Thompson EW and Williams ED: Mesenchymal-to-epithelial
transition facilitates bladder cancer metastasis: role of
fibroblast growth factor receptor-2. Cancer Res. 66:11271–11278.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marek L, Ware KE, Fritzsche A, Hercule P,
Helton WR, Smith JE, et al: Fibroblast growth factor (FGF) and FGF
receptor-mediated autocrine signaling in non-small-cell lung cancer
cells. Mol Pharmacol. 75:196–207. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yan G, Fukabori Y, McBride G,
Nikolaropoulos S and McKeehan WL: Exon switching and activation of
stromal and embryonic fibroblast growth factor (FGF)-FGF receptor
genes in prostate epithelial cells accompany stromal independence
and malignancy. Mol Cell Biol. 13:4513–4522. 1993.PubMed/NCBI
|
|
27
|
Oltean S, Sorg BS, Albrecht T, Bonano VI,
Brazas RM, Dewhirst MW, et al: Alternative inclusion of fibroblast
growth factor receptor 2 exon IIIc in Dunning prostate tumors
reveals unexpected epithelial mesenchymal plasticity. Proc Natl
Acad Sci USA. 103:14116–14121. 2006. View Article : Google Scholar
|
|
28
|
Luqmani YA, Graham M and Coombes RC:
Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in
normal and malignant human breast, and comparison with other normal
tissues. Br J Cancer. 6:273–280. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishikawa A, Kudo M, Nakazawa N, Onda M,
Ishiwata T, Takeshita T and Naito Z: Expression of keratinocyte
growth factor and its receptor in human endometrial cancer in
cooperation with steroid hormones. Int J Oncol. 32:565–574.
2008.PubMed/NCBI
|
|
30
|
Kurban G, Ishiwata T, Kudo M, Yokoyama M,
Sugisaki Y and Naito Z: Expression of keratinocyte growth factor
receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer. Oncol
Rep. 11:987–991. 2004.PubMed/NCBI
|
|
31
|
Matsunobu T, Ishiwata T, Yoshino M,
Watanabe M, Kudo M, Matsumoto K, et al: Expression of keratinocyte
growth factor receptor correlates with expansive growth and early
stage of gastric cancer. Int J Oncol. 28:307–314. 2006.PubMed/NCBI
|
|
32
|
Cho K, Ishiwata T, Uchida E, Nakazawa N,
Korc M, Naito Z and Tajiri T: Enhanced expression of keratinocyte
growth factor and its receptor correlates with venous invasion in
pancreatic cancer. Am J Pathol. 170:1964–1974. 2007. View Article : Google Scholar : PubMed/NCBI
|
